Dynamic Actin Filament Traps Mediate Active Diffusion of Vesicular Stomatitis Virus Ribonucleoproteins.


Journal

Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724

Informations de publication

Date de publication:
12 10 2022
Historique:
pubmed: 23 9 2022
medline: 15 10 2022
entrez: 22 9 2022
Statut: ppublish

Résumé

A recently developed variational Bayesian analysis using pattern recognition and machine learning of single viral ribonucleoprotein (RNP) particle tracks in the cytoplasm of living cells provides a quantitative molecular explanation for active diffusion, a concept previously "explained" largely by hypothetical models based on indirect analyses such as continuum microrheology. Machine learning shows that vesicular stomatitis virus (VSV) RNP particles are temporarily confined to dynamic traps or pores made up of cytoskeletal elements. Active diffusion occurs when the particles escape from one trap to a nearby trap. In this paper, we demonstrate that actin filament disruption increased RNP mobility by increasing trap size. Inhibition of nonmuscle myosin II ATPase decreased mobility by decreasing trap size. Trap sizes were observed to fluctuate with time, dependent on nonmuscle myosin II activity. This model for active diffusion is likely to account for the dominant motion of other viral and cellular elements.

Identifiants

pubmed: 36135365
doi: 10.1128/jvi.00934-22
pmc: PMC9555154
doi:

Substances chimiques

RNA, Viral 0
Ribonucleoproteins 0
Viral Proteins 0
Adenosine Triphosphate 8L70Q75FXE
Adenosine Triphosphatases EC 3.6.1.-
Myosin Type II EC 3.6.1.-

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0093422

Subventions

Organisme : NCI NIH HHS
ID : P30 CA012197
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI120623
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI007401
Pays : United States

Références

Biophys J. 2009 Dec 16;97(12):3196-205
pubmed: 20006957
Traffic. 2022 Feb 10;:
pubmed: 35146839
Future Med Chem. 2013 Jan;5(1):41-52
pubmed: 23256812
Nat Commun. 2020 Jan 7;11(1):23
pubmed: 31911620
J Biol Chem. 1986 Feb 15;261(5):2041-50
pubmed: 3944126
FEBS Lett. 1987 Mar 23;213(2):316-8
pubmed: 3556584
Biochemistry. 1996 May 21;35(20):6508-18
pubmed: 8639598
Int Rev Cytol. 2000;192:189-221
pubmed: 10553280
Sci Rep. 2018 Sep 5;8(1):13294
pubmed: 30185883
Eur Biophys J. 2016 Apr;45(3):269-77
pubmed: 26538332
Trends Cell Biol. 2009 Sep;19(9):423-7
pubmed: 19699642
PLoS Pathog. 2010 Jun 24;6(6):e1000958
pubmed: 20585632
Methods Mol Biol. 2022;2364:3-24
pubmed: 34542846
mBio. 2018 Sep 4;9(5):
pubmed: 30181255
Science. 2007 Jan 19;315(5810):370-3
pubmed: 17234946
Biophys J. 1996 Sep;71(3):1228-34
pubmed: 8873997
J Virol. 2001 Dec;75(24):12169-81
pubmed: 11711608
Curr Biol. 2018 Oct 8;28(19):3183-3192.e2
pubmed: 30270183
Phys Rev Lett. 2005 Dec 31;95(26):268102
pubmed: 16486411
Expert Opin Biol Ther. 2020 Oct;20(10):1187-1201
pubmed: 32602788
PLoS One. 2010 Jun 07;5(6):e10994
pubmed: 20543880
Phys Rev Lett. 2019 Jul 12;123(2):028001
pubmed: 31386530
J Biol Chem. 2004 Aug 20;279(34):35557-63
pubmed: 15205456
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Int J Mol Sci. 2021 Sep 26;22(19):
pubmed: 34638710
J Cell Biol. 1995 Nov;131(4):989-1002
pubmed: 7490299
Biophys J. 2022 Apr 5;121(7):1205-1218
pubmed: 35202608
Front Cell Dev Biol. 2017 Sep 14;5:81
pubmed: 28959689
Sci Rep. 2020 Jun 30;10(1):10643
pubmed: 32606395
Learn Mem. 2017 Jan 17;24(2):70-75
pubmed: 28096495
J Cell Sci. 2009 Aug 15;122(Pt 16):2914-23
pubmed: 19638410
Nature. 2010 Jan 28;463(7280):485-92
pubmed: 20110992
Biomech Model Mechanobiol. 2015 Nov;14(6):1335-47
pubmed: 25929519
J Virol. 2010 Aug;84(15):7543-57
pubmed: 20484502
J Virol. 2016 Jun 10;90(13):6159-70
pubmed: 27122580
J Virol. 2006 Jul;80(13):6368-77
pubmed: 16775325
Biochemistry. 1991 Feb 19;30(7):1973-80
pubmed: 1899622
Methods Mol Biol. 2022;2364:25-52
pubmed: 34542847
Nat Commun. 2017 Jul 5;8(1):58
pubmed: 28680096

Auteurs

Steven J Moran (SJ)

Department of Biochemistry, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.

Shelby Puckett (S)

Department of Biochemistry, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.

David A Ornelles (DA)

Department of Microbiology and Immunology, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.

Jed C Macosko (JC)

Department of Physics, Wake Forest Universitygrid.241167.7, Winston-Salem, North Carolina, USA.

George Holzwarth (G)

Department of Physics, Wake Forest Universitygrid.241167.7, Winston-Salem, North Carolina, USA.

Douglas S Lyles (DS)

Department of Biochemistry, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH